This poster reaffirms tirzepatide’s use in patients with HIV. As patients with HIV are diagnosed with diabetes at a higher rate, it is important that GLP-1 RAs are known to be safe and effective for ...

Type 2 diabetes is a major global health concern — in 2017, around 6.28% of the world’s population lived with the condition, a proportion that is expected to rise to 7% by 2030. There are several ...

Weight loss is notoriously hard to maintain. Within a few years most people regain the pounds they initially lose, whether ...

The narrative surrounding perimenopause often reads like a predetermined script of inevitable weight gain and declining health. Social media platforms overflow with cautionary tales, painting a ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at a steady rate, returning to ...

We've been talking about weight control in the last two posts. I said last time we would talk about the issue of acceptance. Now, as one of my old patients used to say, "Acceptance is a tough nut to ...

In young adults with overweight, inulin-propionate ester (IPE), a novel food ingredient that aims to mimic the beneficial role of dietary fiber by boosting production of short-chain fatty acids in the ...

The market is inundated with various supplements promising miraculous results in pursuing weight loss and increased energy. Among these, Lipo Bites has emerged as a compelling contender, capturing the ...